Hint mode is switched on Switch off
For swift navigation between sections

Ascletis Pharma
LEI 254900SKEFCO9I3GPL05

PDF download

Choose all Reset all
Download Cancel
Organization name
Ascletis Pharma Inc.
Country name
China
Country of registration
Cayman Islands
Industry
Miscellaneous Healthcare: Products and Services
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Awards

News

20/03/2025 Ascletis Pharma to Host Obesity Portfolio Webinar on April 2, 2025
02/07/2024 Ascletis Pharma Board Approves Up to HK$200 Million Share Buyback Plan; Shares Surge 13%
08/11/2023 Dr. Jinzi J. Wu Presents at the 10th International Workshop on HBV Cure 2023
All organization news

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    254900SKEFCO9I3GPL05
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • NACE
    *** ***
  • NAICS
    *** ***
Registration is required to get access.